Stempoint Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4M Sell
1,215,743
-123,636
-9% -$2.69M 5.46% 3
2025
Q4
$28.1M Sell
1,339,379
-26,826
-2% -$468K 4.83% 4
2025
Q3
$21M Sell
1,366,205
-1,006,429
-42% -$13.2M 4.24% 6
2025
Q2
$22.2M Buy
2,372,634
+774,040
+48% +$8.52M 7.15% 1
2025
Q1
$19.6M Sell
1,598,594
-1,274,007
-44% -$18M 6.27% 2
2024
Q4
$38M Buy
2,872,601
+1,141,410
+66% +$19.5M 9.52% 1
2024
Q3
$33.3M Buy
1,731,191
+319,015
+23% +$6.59M 9.99% 1
2024
Q2
$29M Buy
1,412,176
+311,188
+28% +$6.51M 8.53% 1
2024
Q1
$26.2M Buy
1,100,988
+6,494
+0.6% +$145K 7% 3
2023
Q4
$23.7M Buy
+1,094,494
New +$16.8M 6.8% 2

Other funds holding SNDX